1.145

1.29% -0.015

Bionano Genomics Inc (BNGO)

Overview News Price History Option Chain Financials Why BNGO Down? Discussions Forecast Stock Split

Bionano Genomics Inc stock is traded at $1.145, with a volume of 82,209. It is down -1.29% in the last 24 hours and down -2.14% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Previous Close:

$1.16

Open:

$1.15

24h Volume:

82,209

Relative Volume:

0.56

Market Cap:

$13.09M

Revenue:

$28.74M

Net Income/Loss:

$-31.60M

P/E Ratio:

-0.2254

EPS:

-5.0805

Net Cash Flow:

$-19.30M

1W Performance:

+1.33%

1M Performance:

-2.14%

6M Performance:

-28.44%

1Y Performance:

-65.20%

1-Day Range:

$1.13

$1.1597

1-Week Range:

$1.12

$1.18

52-Week Range:

$1.06

$5.50

Bionano Genomics Inc Stock (BNGO) Company Profile

Name

Bionano Genomics Inc

Sector

Healthcare (1100)

Industry

Medical Instruments & Supplies (56)

Phone

(858) 888-7600

Address

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA

Employee

Twitter

@bionanogenomics

Next Earnings Date

2026-08-13

Latest SEC Filings

BNGO's Discussions on Twitter

Compare BNGO vs ISRG, BDX, MDLN, ALC, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNGO Bionano Genomics Inc	1.1411	13.31M	28.74M	-31.60M	-19.30M	-5.0805
ISRG Intuitive Surgical Inc	426.08	153.29B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	157.25	42.86B	21.37B	1.41B	3.07B	3.9437
MDLN Medline Inc	42.97	36.15B	29.14B	1.07B	1.05B	1.1956
ALC Alcon Inc	67.11	33.32B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	218.78	31.68B	5.54B	1.52B	1.74B	10.37

Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-12-22	Resumed	BTIG Research	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Jun-16-21	Initiated	BTIG Research	Buy
Sep-24-20	Initiated	Ladenburg Thalmann	Buy
Apr-08-20	Initiated	Oppenheimer	Outperform

View All

Bionano Genomics Inc Stock (BNGO) Latest News

Jul 02, 2026

Bionano Genomics, Inc. Announces Appointment of Alex Hastie to Chief Scientific Officer, Effective July 20, 2026 - marketscreener.com

Jun 25, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 25, 2026

Bionano Genomics Names Alex Hastie Chief Scientific Officer - The Globe and Mail

Jun 25, 2026

Jun 24, 2026

Bionano Genomics appoints Alex Hastie as chief scientific officer - Investing.com UK

Jun 24, 2026

Bionano Genomics appoints Alex Hastie as chief scientific officer By Investing.com - Investing.com South Africa

Jun 24, 2026

Bionano Genomics Appoints Dr. Alex Hastie as Chief Scientific Officer to Drive Innovation in Optical Genome Mapping - Minichart

Jun 24, 2026

Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer - Quiver Quantitative

Jun 24, 2026

Bionano appoints Alex Hastie as Chief Scientific Officer to lead global science strategy - TradingView

Jun 24, 2026

Bionano Announces Hiring of Chief Scientific Officer - marketscreener.com

Jun 24, 2026

Alex Hastie returns as Chief Scientific Officer at Bionano Genomics (NASDAQ: BNGO) - Stock Titan

Jun 24, 2026

Bionano brings back OGM pioneer to lead science strategy July 20 - Stock Titan

Jun 24, 2026

Jun 23, 2026